Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Exchange Rate Effect: 2023-2025

Historic Exchange Rate Effect for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Sep 2025 value amounting to -$4,000.

  • Tonix Pharmaceuticals Holding's Exchange Rate Effect rose 76.47% to -$4,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $7,000, marking a year-over-year increase of 123.33%. This contributed to the annual value of $4,000 for FY2024, which is 106.15% up from last year.
  • Tonix Pharmaceuticals Holding's Exchange Rate Effect amounted to -$4,000 in Q3 2025, which was down 0.00% from -$4,000 recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's Exchange Rate Effect's 5-year high stood at $24,000 during Q4 2024, with a 5-year trough of -$43,000 in Q1 2023.
  • Its 3-year average for Exchange Rate Effect is -$7,800, with a median of -$6,500 in 2024.
  • As far as peak fluctuations go, Tonix Pharmaceuticals Holding's Exchange Rate Effect spiked by 340.00% in 2024, and later slumped by 500.00% in 2025.
  • Tonix Pharmaceuticals Holding's Exchange Rate Effect (Quarterly) stood at -$10,000 in 2023, then surged by 340.00% to $24,000 in 2024, then spiked by 76.47% to -$4,000 in 2025.
  • Its last three reported values are -$4,000 in Q3 2025, -$4,000 for Q2 2025, and -$9,000 during Q1 2025.